BioWorld - Sunday, February 16, 2025
See today's BioWorld
To read the full article sign up for free or sign in.

Eyegate sees top-line corneal wound win as unlocking path to U.S. de novo filing

Nov. 22, 2019
By Michael Fitzhugh
No Comments
Shares of Eyegate Pharmaceuticals Inc. (NASDAQ:EYEG) rose 54.8% to $7.09 Friday on news that its ocular bandage gel (OBG) proved superior to standard of care in healing corneal wounds following photorefractive keratectomy (PRK) surgery.
BioWorld Clinical Ocular